In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate).

Abstract We chemically synthesized two different cationic lipids consisting of a core of lysine, two C-14 hydrocarbon chains, and either aspartatic acid or glutamic acid. The lipids were assigned the acronyms, DMKD and DMKE. Cationic liposomes prepared with the two different lipids were tested for their gene-transferring capabilities in various cell lines compared with that of control DOTAP liposomes. Under the same experimental conditions, the order of in vitro gene transfection efficiency was DMKE ≥ DMKD > DOTAP. To identify the parameters influencing transfection efficiency, the DNA-binding affinities of the liposomes were compared and changes in particle size and surface charge were examined after complex formation. Both the DNA-binding affinity of the liposomes and the cell surface-binding affinity of the liposome-pDNA complexes were crucial for gene transfection. In addition, intravenously administered DMKE and DMKD liposomes exhibited different biodistribution characteristics and intensity of in vivo organ transfection from the DOTAP liposomes. Compared to the DOTAP liposomes, they were more readily transferred to the liver. Interestingly, when they were directly injected into tumor tissues, the DMKE lipoplexes were able to induce more efficient transgene expression in these tissues than the DOTAP and DMKD lipoplexes. This study suggests that a small difference in the cationic lipid backbone structure significantly affects gene-transferring capabilities. DMKE and DMKD liposomes can be utilized as efficient gene-transferring vehicles for hepatic or intra-tumoral gene transfection.

[1]  Hong-Sung Kim,et al.  Gene-transferring efficiencies of novel diamino cationic lipids with varied hydrocarbon chains. , 2004, Bioconjugate chemistry.

[2]  B. Pitt,et al.  Prolonged gene expression in mouse lung endothelial cells following transfection with Epstein–Barr virus-based episomal plasmid , 2003, Gene Therapy.

[3]  L. Huang,et al.  In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes , 1997, Gene Therapy.

[4]  Y. Song,et al.  Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. , 1997, Human gene therapy.

[5]  M. Hung,et al.  Nonviral vectors for gene therapy , 1999 .

[6]  M. Kay,et al.  Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  H. Hofland,et al.  Formation of stable cationic lipid/DNA complexes for gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Eric C. Olivares,et al.  In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Feng Liu,et al.  Development of non-viral vectors for systemic gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[10]  M. D. Brown,et al.  Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. , 2000, Bioconjugate chemistry.

[11]  F. Szoka,et al.  Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. , 1999, Human gene therapy.

[12]  F. Szoka,et al.  Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes , 1999, Gene Therapy.

[13]  S. Stass,et al.  Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes , 2000, Gene Therapy.

[14]  R. Müller,et al.  Chimeric transcriptional control units for improved liver-specific transgene expression. , 2003, Gene.

[15]  C. Férec,et al.  Biodistribution study of phosphonolipids: a class of non‐viral vectors efficient in mice lung‐directed gene transfer , 2003, The journal of gene medicine.

[16]  D. Largaespada,et al.  Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. , 2005, Blood.

[17]  K. Überla,et al.  Increased non‐viral gene transfer levels in mice by concentration of cationic lipid DNA complexes formed under optimized conditions , 2003, The journal of gene medicine.

[18]  J. Marshall,et al.  A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[20]  L. Huang,et al.  A novel cationic liposome reagent for efficient transfection of mammalian cells. , 1991, Biochemical and biophysical research communications.

[21]  E. Schacht,et al.  Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[22]  K. Loeb,et al.  Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  D. Hoekstra,et al.  Molecular Shape of the Cationic Lipid Controls the Structure of Cationic Lipid/Dioleylphosphatidylethanolamine-DNA Complexes and the Efficiency of Gene Delivery* , 2001, The Journal of Biological Chemistry.

[24]  K. Anwer,et al.  Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. , 1998, Human Gene Therapy.

[25]  F. Szoka,et al.  Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components , 2001, Gene Therapy.